Durvalumab for Stage III EGFR-Mutated Non-Small Cell Lung Cancer After Definitive Chemoradiotherapy.
暂无分享,去创建一个
Summer S. Han | J. Neal | H. Wakelee | B. Loo | M. Diehn | J. Riess | R. Salgia | A. Amini | Isa Mambetsariev | J. Naidoo | C. McCoach | J. Hellyer | J. Aredo | S. Padda | E. Cabebe | T. Abuali